Skip to main content
Premium Trial:

Request an Annual Quote

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

For a paper in Genome Biology, a pair of investigators at the San Francisco-based Calico Life Sciences considers the genetic and biochemical factors influencing messenger RNA (mRNA) degradation rates in humans and mice. Using transcriptome-wide mRNA half-life patterns found in dozens of human or mouse datasets, the team used available genetic and biochemical clues to put together and train statistical models such as Saluki — a hybrid machine learning-based tool for predict mRNA half-life based on RNA splice site, codon, RNA-binding, and other annotated mRNA features. "Saluki predicts the impact of RNA sequences and genetic mutations therein on mRNA stability, in agreement with functional measurements derived from massively parallel reporter assays," the authors explain, noting that the approach was also assessed with in silico saturation mutagenesis experiments. Together, these and other results suggest that Saluki "succinctly captures many of the known determinants of mRNA half-life and can be rapidly deployed to predict the functional consequences of arbitrary mutations in the transcriptome."

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.